Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience

Antonella Meloni,Laura Pistoia,Amalia Lupi,Riccardo Righi,Antonino Vallone,Massimiliano Missere,Stefania Renne,Priscilla Fina,Ada Riva,Maria Rita Gamberini,Valerio Cecinati,Francesco Sorrentino,Rosamaria Rosso,Giuseppe Messina,Paolo Ricchi,Vincenzo Positano,Sophie Mavrogeni,Emilio Quaia,Filippo Cademartiri,Alessia Pepe
DOI: https://doi.org/10.3390/tomography9050136
2023-09-11
Tomography
Abstract:Background: The E-MIOT (Extension-Myocardial Iron Overload in Thalassemia) project is an Italian Network assuring high-quality quantification of tissue iron overload by magnetic resonance imaging (MRI). We evaluated the impact of the COVID-19 pandemic on E-MIOT services. Methods: The activity of the E-MIOT Network MRI centers in the year 2020 was compared with that of 2019. A survey evaluated whether the availability of MRI slots for patients with hemoglobinopathies was reduced and why. Results: The total number of MRI scans was 656 in 2019 and 350 in 2020, with an overall decline of 46.4% (first MRI: 71.7%, follow-up MRI: 36.9%), a marked decline (86.9%) in the period March-June 2020, and a reduction in the gap between the two years in the period July-September. A new drop (41.4%) was recorded in the period October-December for two centers, due to the general reduction in the total amount of MRIs/day for sanitization procedures. In some centers, patients refused MRI scans for fear of getting COVID. Drops in the MRI services >80% were found for patients coming from a region without an active MRI site. Conclusions: The COVID-19 pandemic had a strong negative impact on MRI multi-organ iron quantification, with a worsening in the management of patients with hemoglobinopathies.
What problem does this paper attempt to address?